Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€21.90
27.10.14
€25.62
12.12.14
11.39%
12.12.14

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
gerihouse 
02.08.19 50%
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€80.57
10.10.14
€91.00
17.11.14
6.63%
17.11.14

gerihouse 
02.08.19 50%
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€80.57
10.10.14
€91.00
17.11.14
6.63%
17.11.14

gerihouse 
02.08.19 50%
buy
Henry Schein Inc.

Start price
Target price
Perf. (%)
€46.03
06.10.14
€52.50
07.11.14
12.20%
07.11.14

gerihouse 
02.08.19 50%
buy
Henry Schein Inc.

Start price
Target price
Perf. (%)
€46.03
06.10.14
€52.50
07.11.14
12.20%
07.11.14

gerihouse 
02.08.19 50%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€21.31
22.04.14
€28.46
22.09.14
6.63%
22.09.14

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
gerihouse 
02.08.19 50%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€21.31
22.04.14
€28.46
22.09.14
6.63%
22.09.14

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
gerihouse 
02.08.19 50%
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€72.48
22.04.14
€80.00
07.07.14
7.34%
07.07.14

gerihouse 
02.08.19 50%
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€72.48
22.04.14
€80.00
07.07.14
7.34%
07.07.14

gerihouse 
02.08.19 50%
buy
Cerner Corp.

Start price
Target price
Perf. (%)
€35.15
18.03.13
€38.50
01.07.13
4.80%
01.07.13

Finanzgonzo 
18.03.13 50%
buy
Cerner Corp.

Start price
Target price
Perf. (%)
€35.15
18.03.13
€38.50
01.07.13
4.80%
01.07.13

Finanzgonzo 
18.03.13 50%
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€51.73
14.06.12
€60.00
17.07.12
8.36%
17.07.12

gerihouse 
02.08.19 50%
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€51.73
14.06.12
€60.00
17.07.12
8.36%
17.07.12

gerihouse 
02.08.19 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€14.68
27.07.11
€18.00
26.01.12
25.99%
26.01.12

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
ValueFreak 
05.08.19 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€14.68
27.07.11
€18.00
26.01.12
25.99%
26.01.12

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
ValueFreak 
05.08.19 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€14.68
27.07.11
€18.00
26.01.12
25.99%
26.01.12

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
ValueFreak 
05.08.19 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€13.88
21.11.10
€22.50
23.05.11
4.14%
23.05.11

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
ValueFreak 
05.08.19 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€13.88
21.11.10
€22.50
23.05.11
4.14%
23.05.11

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
ValueFreak 
05.08.19 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€13.88
21.11.10
€22.50
23.05.11
4.14%
23.05.11

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
ValueFreak 
05.08.19 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€15.52
25.04.10
€22.29
25.10.10
-9.83%
25.10.10

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
ValueFreak 
05.08.19 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€15.52
25.04.10
€22.29
25.10.10
-9.83%
25.10.10

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
ValueFreak 
05.08.19 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€15.52
25.04.10
€22.29
25.10.10
-9.83%
25.10.10

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
ValueFreak 
05.08.19 50%
buy
Merck & Co. Inc.

Start price
Target price
Perf. (%)
€19.18
27.05.09
€25.00
19.11.09
26.88%
19.11.09

Xetrakarl 
14.08.19 50%
buy
Merck & Co. Inc.

Start price
Target price
Perf. (%)
€19.18
27.05.09
€25.00
19.11.09
26.88%
19.11.09

Xetrakarl 
14.08.19 50%
buy
Celgene Corp.

Start price
Target price
Perf. (%)
€20.81
04.05.08
€22.00
18.09.08
6.80%
18.09.08

Riccardo 
18.08.19 50%